Ensemble Deep Learning Algorithm for Structural Heart Disease Screening Using Electrocardiographic Images: PRESENT SHD.
Summary
An ensemble deep learning model operating on ECG images (not raw waveforms) detected multiple left-sided structural heart diseases with AUROCs ~0.85–0.90 across 4 U.S. hospitals and in ELSA-Brasil, with sensitivities ~88–96%. The model generalized to smartphone photographs of printed/monitor ECGs and predicted 2–4-fold higher risk of incident SHD/HF, independent of clinical factors.
Key Findings
- Development cohort: 261,228 ECGs from 93,693 patients; external validation included 11,023 (YNHH test), 44,591 (4 U.S. hospitals), and 3,014 (ELSA-Brasil).
- Composite PRESENT-SHD achieved AUROC 0.886 (YNHH), 0.854–0.900 (external hospitals), and 0.853 (ELSA-Brasil) with sensitivities ~88–96% and specificities ~51–66%.
- Generalized to smartphone photos of ECGs and predicted 2–4× higher risk of incident SHD/HF in clinical cohorts and UK Biobank, independent of traditional risk factors.
Clinical Implications
ECG-image AI screening can triage patients for echocardiography, prioritize valve disease and LV dysfunction detection, and longitudinally flag patients at high risk for SHD/HF, potentially embedding into routine ECG workflows (including smartphone-based capture).
Why It Matters
Image-based ECG AI that is robust across centers and capture methods can democratize SHD screening where echocardiography access is limited, and enable scalable risk stratification.
Limitations
- Labeling relies on echocardiography within 30 days; potential misclassification and spectrum bias.
- Retrospective development; prospective impact and cost-effectiveness trials are needed to confirm clinical utility.
Future Directions
Prospective, randomized deployment trials assessing clinical impact, workflow integration, and health economics; calibration for diverse devices and care settings; bias auditing across demographic subgroups.
Study Information
- Study Type
- Cohort/Diagnostic development with external validation
- Research Domain
- Diagnosis/Prognosis
- Evidence Level
- II - Well-designed diagnostic cohort with multi-center external validation and prognostic analyses.
- Study Design
- OTHER